(Q48854657)

16 February 2018

title

Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes. (English)

1 reference

16 February 2018

3

Halldin C

1 reference

16 February 2018

author name string

Hall H

1

1 reference

16 February 2018

Wedel I

2

1 reference

16 February 2018

Kopp J

4

1 reference

16 February 2018

Farde L

5

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 December 1990

1 reference

16 February 2018

Journal of Neurochemistry

published in

1 reference

16 February 2018

volume

55

1 reference

16 February 2018

issue

6

1 reference

16 February 2018

page(s)

2048-2057

1 reference

16 February 2018

Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Alternative splicing directs the expression of two D2 dopamine receptor isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Evaluation of a semiautomatic filtration technique for receptor binding studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

A new mathematical treatment of changes of ionic concentration in muscle and nerve under the action of electric currents, with a theory as to their mode of excitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Multiple receptors for dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Elevation of brain neuroleptic/dopamine receptors in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Sulpiride isomers exhibit reversed stereospecificity for D-1 and D-2 dopamine receptors in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Serotonergic component of neuroleptic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Multiple D2 dopamine receptors produced by alternative RNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Contamination of serotonin-2 binding sites by an alpha-1 adrenergic component in assays with (3H) spiperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Antipsychotic drug doses and neuroleptic/dopamine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

The major dopamine D2 receptor: molecular analysis of the human D2A subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Two dopamine receptors: biochemistry, physiology and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1990.TB05794.X

10.1111/J.1471-4159.1990.TB05794.X

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

release_3x7lzugpmjfi7jiwe3pz5nzzmm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3x7lzugpmjfi7jiwe3pz5nzzmm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

16 February 2018